Food and Drug Administration – Page 9

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.

By Teddy Rosenbluth

Bristol Myers Squibb Company Clinical Trials Dopamine Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Psychiatry and Psychiatrists Psychology and Psychologists Regulation and Deregulation of Industry Research Schizophrenia Therapy and Rehabilitation Weight

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

By Ellen Barry and Christina Jewett

AstraZeneca PLC Drugs (Pharmaceuticals) Food and Drug Administration Influenza Vaccination and Immunization

Nasal Flu Vaccine Is Approved for At-Home Use

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.

By Christina Jewett

Agriculture and Farming Bacteria Centers for Disease Control and Prevention Disease Rates Eggs Factory Farming Food and Drug Administration Food Contamination and Poisoning Infections Recalls and Bans of Products Salmonella (Bacteria) Wisconsin

Salmonella Outbreak Prompts Egg Recall by Wisconsin Farm

Officials said 65 people in nine states have been infected in the outbreak, which has been traced to an egg farm. No deaths have been reported.

By Orlando Mayorquin

mosaec